diphenhydramine has been researched along with Benign Neoplasms, Brain in 2 studies
Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vemurafenib and dabrafenib are both orally bioavailable small molecule agents that block mitogen activated protein kinase signalling in patients with melanoma and BRAF(V600E) mutation." | 7.81 | Successful desensitization protocol for hypersensitivity reaction probably caused by dabrafenib in a patient with metastatic melanoma. ( Abu-Amna, M; Bar-Sela, G; Hadad, S; Haim, N; Shahar, E, 2015) |
| "Vemurafenib and dabrafenib are both orally bioavailable small molecule agents that block mitogen activated protein kinase signalling in patients with melanoma and BRAF(V600E) mutation." | 3.81 | Successful desensitization protocol for hypersensitivity reaction probably caused by dabrafenib in a patient with metastatic melanoma. ( Abu-Amna, M; Bar-Sela, G; Hadad, S; Haim, N; Shahar, E, 2015) |
| "Carboplatin is the drug of choice for the treatment of nonresectable astrocytomas in children, but patients who are intolerant may require cranial irradiation which is associated with significant morbidity." | 3.69 | Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions. ( Broome, CB; Friedman, HS; Schiff, RI, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Sela, G | 1 |
| Abu-Amna, M | 1 |
| Hadad, S | 1 |
| Haim, N | 1 |
| Shahar, E | 1 |
| Broome, CB | 1 |
| Schiff, RI | 1 |
| Friedman, HS | 1 |
2 other studies available for diphenhydramine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Successful desensitization protocol for hypersensitivity reaction probably caused by dabrafenib in a patient with metastatic melanoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Brain Neoplasms; Desensitization, Immunologic; Dexa | 2015 |
Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.
Topics: Anaphylaxis; Anti-Allergic Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Astrocytoma; Bra | 1996 |